You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery

Article metrics

Article menu

Download PDFPDF

XML
Cardiovascular and Metabolic Risk
Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery

 

Online download statistics by month:

Online download statistics by month: September 2019 to March 2024

AbstractFullPdf
Sep 2019376354139
Oct 201910610249
Nov 20196966193
Dec 2019727099
Jan 2020595565
Feb 2020464650
Mar 2020424222
Apr 2020313129
May 2020484540
Jun 2020454535
Jul 2020504933
Aug 2020655858
Sep 20206660124
Oct 2020464642
Nov 2020383722
Dec 2020464430
Jan 2021393926
Feb 2021383735
Mar 2021474651
Apr 2021423957
May 2021353436
Jun 2021373517
Jul 2021363421
Aug 2021615829
Sep 2021616041
Oct 2021555044
Nov 2021757240
Dec 2021535118
Jan 2022232413
Feb 2022394220
Mar 2022545338
Apr 2022535229
May 2022504931
Jun 2022242317
Jul 2022373620
Aug 2022736540
Sep 2022464435
Oct 2022424026
Nov 2022312919
Dec 2022394121
Jan 2023514627
Feb 2023767823
Mar 2023464722
Apr 2023494819
May 2023313014
Jul 2023232214
Aug 2023464418
Sep 2023333217
Oct 2023656726
Nov 2023635815
Dec 2023252413
Jan 2024191927
Feb 2024171512
Mar 2024363014
Total287527632015